AFX — Carl Zeiss Meditec AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual income statement for Carl Zeiss Meditec AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,335	1,647	1,903	2,089	2,066
Cost of Revenue
Gross Profit	746	967	1,128	1,206	1,089
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,158	1,273	1,506	1,741	1,872
Operating Profit	178	374	397	348	194
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	179	339	403	413	241
Provision for Income Taxes
Net Income After Taxes	123	238	296	292	180
Minority Interest
Net Income Before Extraordinary Items
Net Income	122	236	294	290	179
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	122	236	294	290	179
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.42	2.62	3.29	3.25	2.01
Dividends per Share